GLP-1 is one of the three receptors activated by retatrutide. It is also the target of semaglutide, which makes shared receptor activity an easy point of comparison at the molecular level.
GLP-1 as one of three targets
A shared target cannot tell you how two medicines compare in people. Molecules can differ in activity, drug exposure and trial design, and a study of the whole molecule cannot isolate the contribution of one receptor.
How to interpret the evidence
Use receptor studies to understand design. Use randomized comparisons to answer a question about clinical effects.
Start with the intervention name and receptor targets, then follow the links to the original trial if you want to check what was measured in people.